Member Info for Magsy18

Still no sources strongboes.

Seems that you're a liar. Why would you make up that multiple sources state that FDA is likely next week?

Desperate.

I do dig around, didn't happen to come across any good source which suggested FDA is highly likely next week. Don't share them because I asked you, everybody on this board would benefit from your multiple sources.

What are the sources for FDA highly likely to land?

Ah yes, apologies, I remember the board discussing this a couple of months ago. I can only assume it is such a tiny order that it's almost insignificant.

Still, there is no way that if we had sold £1m worth that we wouldn't have been told. DB wouldn't give sales details in two scenarios. One 'he does not want to' and two, 'he does not have any to report'. Of course you assume the first. You also assume that it's extremely likely that we have been increasing the number of sales we have over the last few months day by day.

Maybe I am ignorant but I cannot believe that anyone would seriously believe that DB would not announce sales which generated more revenue than the entirety of the companies previous financial year.

Ok so as it states on the website they haven't completed any sales, it's all intent subject to approvals. These are the same indicative sales and the same value that were referred to months ago.

Strongboes there is no way that GDR wouldn't release news on completed sales as they know that even if we completed £1m of sales that it would move the share price as it did with ODX and NCYT.

Got the link strongboes for where it says we have sold tests?

drlong, do you have a problem with people repeating the same message over and over again when it's signalling something positive for GDR? I haven't seen you calling out people who do this.

Yes we need patience but let's be honest, this has taken far longer than anybody expected including DB himself. NCYT is a shining example of how short some of these timelines could have been in different cicumstances.

If the argument is that the strategy that GDR employed takes more time than some of it's competitors then it looks like that strategy was a mistake.

I have no motive other than to profit, like everyone else long. People post things on here that I would love to happen every day but thankfully I have integrity and am able to remain more objective than many here. The fact is that the current situation GDR is in just isn't positive and you should have the strength to accept that. I clearly believe positive things can still happen else I wouldn't remain invested.

If people stop repeating their speculative nonsense which in hindsight constantly turns out to be wildly incorrect then I will stop posting things that highlight these things.

It sounds like you need that break from the board drlong, you seem to be stressed.

Why would I care about credibility? I care about being accurate and since May, my outlook has been a damn sight closer to what actually happened than many here.

The current position that GDR finds itself in is not positive but that’s not to say that we don’t have a positive future.

I don’t think we are undervalued compared to AVCT. They are overvalued compared to us.

That’s not really the point. The market don’t value us the same as AVCT and they haven’t for months. That isn’t about to change unless something significant changes here.

There’s no maths to be done here. We won’t get anywhere near AVCT unless/until we get some significant sales news.

I think I refer to GDR more in terms of hindsight trading. Obviously when you look back over the last few months, you can say that the performance of the share price has been poor. But if an approvals RNS had come followed by a decent sales RNS then we would be in a very different place. Both of those RNSs are realistic but unpredictable as to when they may land.

NCYT has turned out to be a very good investment lately but quite a bit of what you wrote you are only able to do in hindsight.

Are they?

Regardless, any good approvals/sales news would have generated plenty of volume to flush out any remaining BGF shares.

I would argue that good sales news before this news would be more effective anyway. Once people know sales are rolling in, news that we are progressing a new set of products alongside the ones that are already bringing in cash would be even better.

I don’t know guys, Occams Razor applies here. I think the team reached a milestone and they wanted to share progress, that’s all.

Today’s RNS wasn’t bad news, it just wasn’t the news people wanted. Why would DB be trying to ‘bury’ the news he released today?

I posted a link where Epistem themselves state they aren’t using GDR test kit.